儿童血浆与粪便代谢物与体重指数及体脂分布的相关性
在中国6至9岁儿童中开展的横断面研究,纳入424名健康儿童(女186名、男238名),用双能X线吸收法测体脂分布,靶向代谢组学测血浆和粪便代谢物,发现多种血浆和粪便代谢物与BMI、BMIZ及体脂分布存在关联。
要点
- 血浆和粪便中的谷氨酰胺等代谢物可能与儿童肥胖的发生发展相关
- 血浆富马酸、甘氨酸、L-谷氨酰胺、甲基丙二酸和琥珀酸及粪便原儿茶酸与BMI、BMIZ和体脂分布呈负相关
- 血浆异戊酸、异戊酰肉碱、L-谷氨酸和焦谷氨酸及多种粪便代谢物与BMI、BMIZ和体脂分布呈正相关
核心结论
- 血浆和粪便代谢物(如谷氨酰胺)可能作为肥胖发生的潜在治疗靶点。
研究设计与样本
- 横断面研究,纳入中国6至9岁健康儿童424名,其中女孩186名、男孩238名。
- 采用双能X线吸收法测定体脂含量及区域脂肪分布。
- 采用靶向代谢组学技术分析血浆和粪便代谢物。
主要发现
- 共准确定量200种血浆代谢物和212种粪便代谢物。
- 通过正交偏最小二乘判别分析和随机森林模型发现9种血浆代谢物和11种粪便代谢物与不同体重状态相关。
- 校正潜在协变量及错误发现率后,血浆富马酸、甘氨酸、L-谷氨酰胺、甲基丙二酸和琥珀酸及粪便原儿茶酸与BMI、BMIZ和体脂分布呈负相关(β -1.373至-.016,pFDR < 0.001-0.031;β -1.008至-.071,pFDR 0.005-0.033)。
- 血浆异戊酸、异戊酰肉碱、L-谷氨酸和焦谷氨酸及粪便3-氨基异丁酸、丁酸、N-乙酰神经氨酸、辛酰肉碱、油酰肉碱、棕榈酰肉碱、硬脂酰肉碱、牛磺鹅去氧胆酸和牛磺去氧胆酸与BMI、BMIZ和体脂分布呈正相关(β .023-2.396,pFDR < 0.001;β .014-1.736,pFDR < 0.001-0.049)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Childhood obesity continues to be a critical public health concern with far-reaching implications for well-being. OBJECTIVE: This study aimed to investigate the association between metabolites in plasma and feces and indicators including body mass index (BMI), BMI for age Z score (BMIZ), and body fat distribution among children aged 6 to 9 years in China. METHODS: This cross-sectional study enrolled 424 healthy children, including 186 girls and 238 boys. Dual-energy X-ray absorptiometry was used to determine the body fat content and regional fat distribution. Plasma and fecal metabolites were analyzed using targeted metabolomic technologies. RESULTS: A total of 200 plasma metabolites and 212 fecal metabolites were accurately quantified via ultra-performance liquid chromatography coupled with tandem mass spectrometry. By using orthogonal projections to latent structures discriminant analysis and random forest model, we discovered that 9 plasma metabolites and 11 fecal metabolites were associated with different weight statuses. After adjusting for potential covariates and false discovery rate correction, multiple linear regression analyses revealed that plasma metabolites (fumaric acid, glycine, l-glutamine, methylmalonic acid, and succinic acid) and fecal metabolites (protocatechuic acid) were negatively associated (β -1.373 to -.016, pFDR < 0.001-0.031; β -1.008 to -.071, pFDR 0.005-0.033), while plasma metabolites (isovaleric acid, isovalerylcarnitine, l-glutamic acid, and pyroglutamic acid) and fecal metabolites (3-aminoisobutanoic acid, butyric acid, N-acetylneuraminic acid, octanoylcarnitine, oleoylcarnitine, palmitoylcarnitine, stearoylcarnitine, taurochenodesoxycholic acid, and taurodeoxycholic acid) exhibited positive associations with BMI, BMIZ, and body fat distribution (β .023-2.396, pFDR < 0.001; β .014-1.736, pFDR < 0.001-0.049). CONCLUSION: Plasma and fecal metabolites such as glutamine may serve as potential therapeutic targets for the development of obesity.
引用
- Hong Z, Zhou K, Wei Y, et al. Associations of Plasma and Fecal Metabolites with Body Mass Index and Body Fat Distribution in Children. J Clin Endocrinol Metab. 2025. PMID: 38703096. doi:10.1210/clinem/dgae296
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。